Biomx Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Biomx Stock Summary

Biomx competes with ZyVersa Therapeutics, Immix Biopharma, Cns Pharmaceuticals, and Sonnet Biotherapeutics. BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel. Biomx operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 103 people.

Biomx Key Financial Ratios

Biomx Key Balance Sheet Accounts

Biomx Key Income Statement Accounts

Biomx Key Cash Accounts

Biomx Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Biomx's current stock value. Our valuation model uses many indicators to compare Biomx value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biomx competition to find correlations between indicators driving Biomx's intrinsic value. More Info.Biomx Inc is considered to be number one stock in return on equity category among its peers. It is regarded fifth in return on asset category among its peers . At present, Biomx's Return On Equity is projected to drop based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biomx by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Biomx Inc Systematic Risk

Today, most investors in Biomx Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Biomx's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Biomx growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Biomx help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Biomx Inc. We use our internally-developed statistical techniques to arrive at the intrinsic value of Biomx Inc based on widely used predictive technical indicators. In general, we focus on analyzing Biomx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Biomx's daily price indicators and compare them against related drivers.

When running Biomx's price analysis, check to measure Biomx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomx is operating at the current time. Most of Biomx's value examination focuses on studying past and present price action to predict the probability of Biomx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomx's price. Additionally, you may evaluate how the addition of Biomx to your portfolios can decrease your overall portfolio volatility.